EQUITY RESEARCH

Transforming Data into Strategic Equity Insights

OVERVIEW

Comprehensive Equity Research Expertise

Lucid’s equity research team delivers in-depth and collaborative analyses that transform complex market data into actionable insights. We concentrate on industries where we possess a unique analytical advantage, leveraging specialized expertise to uncover hidden value. By highlighting small and mid-cap companies often overlooked by larger Wall Street firms, we provide unique perspectives on underrepresented segments of the market

Healthcare

Our healthcare equity research provides a deep dive into the latest developments and market dynamics within the healthcare sector. We focus on emerging trends and industry shifts, delivering targeted insights that inform strategic investment decisions and identify key opportunities in a rapidly evolving field.

Senior Research Team

Christopher Liu, PharmD
Specialty: Oncology

  • Christopher recently joined Lucid as a Managing Director on the healthcare equity research team and brings over seven years of equity research experience with a specialization in oncology. Most recently, Christopher was a Director at Leerink Partners covering the oncology space. Prior to Leerink, Christopher was part of the biotechnology equity research teams at Canaccord Genuity and Oppenheimer. Christopher received his Doctor of Pharmacy from Rutgers University's Ernest Mario School of Pharmacy.

Dev Prasad, Ph.D.
Specialty: Inflammation and Immunology

  • Dev recently joined Lucid as a Senior Vice President and brings ~four years of experience in equity research to Lucid specializing in inflammation and immunology. Prior to joining Lucid, Dev was a member of the equity research teams at Jefferies and JMP Securities. Before his transition into equity research, Dev worked on the product development teams at Fresenius, Sagent Pharmaceuticals and Cubist Pharma. He holds a Ph.D. and a Master of Science in Pharmaceutics and Drug Delivery from the Massachusetts College of Pharmacy and Health Sciences, along with an MBA from Northwestern University's Kellogg School of Management.

Financial Services

Our financial services equity research examines the intricacies of financial markets and regulatory environments. We provide expert analysis and insights that reveal both opportunities and risks, helping clients navigate the complexities of the financial sector with confidence

Senior Research Team

Craig Kucera
Specialty:
Real Estate Investment Trusts (REITs)

  • Craig serves as Managing Director at Lucid Capital Markets in the equity research department focusing on equity REITs. Mr. Kucera has focused on the real estate sector for more than 25 years. Prior to joining Lucid, Mr. Kucera was a Managing Director at B. Riley Securities in the equity research department covering equity REITs. Prior to B. Riley, Mr. Kucera was a Managing Director at Wunderlich Sercurities in the equity research department. Mr. Kucera received his bachelor's degree from Bradley University and holds an MBA from the University of Iowa

Erik Zwick
Specialty:
Business Development Corporations (BDCs)

  • Erik serves as Managing Director at Lucid Capital Markets in the equity research department focusing on specialty finance. Mr. Zwick has focused on the real estate sector for more than 20 years. Prior to joining Lucid, Mr. Zwick was a Managing Director at Hovde Group covering BDCs and community banks. Prior to Hovde, he was a Director of Equity Research at Boenning & Scattergood. Erik received a bachelors degree in Economics from Bates College and holds the Chartered Financial Analyst designation.